Enzyme Digests Eliminate Nonfunctional Env from HIV-1 Particle Surfaces, Leaving Native Env Trimers Intact and Viral Infectivity Unaffected

被引:92
作者
Crooks, Ema T. [1 ]
Tong, Tommy [1 ]
Osawa, Keiko [1 ]
Binley, James M. [1 ]
机构
[1] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEIN COMPLEX; HUMAN MONOCLONAL-ANTIBODIES; TYPE-1; ENVELOPE; NEUTRALIZING ANTIBODY; ENDOPROTEOLYTIC CLEAVAGE; INTRACELLULAR-TRANSPORT; PROTEOLYTIC CLEAVAGE; OLIGOMERIC STRUCTURE; SIGNAL SEQUENCE;
D O I
10.1128/JVI.00154-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
HIV-1 viruses and virus-like particles (VLPs) bear nonnative "junk" forms of envelope (Env) glycoprotein that may undermine the development of antibody responses against functional gp120/gp41 trimers, thereby blunting the ability of particles to elicit neutralizing antibodies. Here, we sought to better understand the nature of junk Env with a view to devising strategies for its removal. Initial studies revealed that native trimers were surprisingly stable in the face of harsh conditions, suggesting that junk Env is unlikely to arise by trimer dissociation or gp120 shedding. Furthermore, the limited gp120 shedding that occurs immediately after synthesis of primary HIV-1 isolate Envs is not caused by aberrant cleavage at the tandem gp120/gp41 cleavage sites, which were found to cleave in a codependent manner. A major VLP contaminant was found to consist of an early, monomeric form of gp160 that is glycosylated in the endoplasmic reticulum (gp160ER) and then bypasses protein maturation and traffics directly into particles. gp160ER was found to bind two copies of monoclonal antibody (MAb) 2G12, consistent with its exclusively high-mannose glycan profile. These findings prompted us to evaluate enzyme digests as a way to remove aberrant Env. Remarkably, sequential glycosidase-protease digests led to a complete or near-complete removal of junk Env from many viral strains, leaving trimers and viral infectivity largely intact. "Trimer VLPs" may be useful neutralizing antibody immunogens.
引用
收藏
页码:5825 / 5839
页数:15
相关论文
共 82 条
[31]  
GEYER H, 1988, J BIOL CHEM, V263, P11760
[32]   Glycosylation site-specific analysis of HIV envelope proteins (JR-FL and CON-S) reveals major differences in glycosylation site occupancy, glycoform profiles, and antigenic epitopes' accessibility [J].
Go, Eden P. ;
Irungu, Janet ;
Zhang, Ying ;
Dalpathado, Dilusha S. ;
Liao, Hua-Xin ;
Sutherland, Laura L. ;
Alam, S. Munir ;
Haynes, Barton F. ;
Desaire, Heather .
JOURNAL OF PROTEOME RESEARCH, 2008, 7 (04) :1660-1674
[33]   N-linked glycan modifications in gp120 of human immunodeficiency virus type 1 subtype C render partial sensitivity to 2G12 antibody neutralization [J].
Gray, Elin S. ;
Moore, Penny L. ;
Pantophlet, Ralph A. ;
Morris, Lynn .
JOURNAL OF VIROLOGY, 2007, 81 (19) :10769-10776
[34]   Induction of neutralizing antibodies against human immunodeficiency virus type 1 primary isolates by Gag-Env pseudovirion immunization [J].
Hammonds, J ;
Chen, XM ;
Fouts, T ;
DeVico, A ;
Montefiori, D ;
Spearman, P .
JOURNAL OF VIROLOGY, 2005, 79 (23) :14804-14814
[35]   Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates [J].
Haynes, Barton F. ;
Montefiori, David C. .
EXPERT REVIEW OF VACCINES, 2006, 5 (03) :347-363
[36]   Anti-V3 Monoclonal Antibodies Display Broad Neutralizing Activities against Multiple HIV-1 Subtypes [J].
Hioe, Catarina E. ;
Wrin, Terri ;
Seaman, Michael S. ;
Yu, Xuesong ;
Wood, Blake ;
Self, Steve ;
Williams, Constance ;
Gorny, Miroslaw K. ;
Zolla-Pazner, Susan .
PLOS ONE, 2010, 5 (04)
[37]   Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1 [J].
Kang, Yun ;
Andjelic, Sofija ;
Binley, James M. ;
Crooks, Emma T. ;
Franti, Michael ;
Iyer, Sai Prasad N. ;
Donovan, Gerald P. ;
Dey, Antu K. ;
Zhu, Ping ;
Roux, Kenneth H. ;
Durso, Robert J. ;
Parsons, Thomas F. ;
Maddon, Paul J. ;
Moore, John P. ;
Olson, William C. .
VACCINE, 2009, 27 (37) :5120-5132
[38]  
KIENY MP, 1988, PROTEIN ENG, V2, P219
[39]   ASSEMBLY OF ASPARAGINE-LINKED OLIGOSACCHARIDES [J].
KORNFELD, R ;
KORNFELD, S .
ANNUAL REVIEW OF BIOCHEMISTRY, 1985, 54 :631-664
[40]   RETRACTED: Fusion-competent vaccines broad neutralization of primary isolates of HIV (Retracted article. See vol 296, pg 1025, 2002) [J].
LaCasse, RA ;
Follis, KE ;
Trahey, M ;
Scarborough, JD ;
Littman, DR ;
Nunberg, JH .
SCIENCE, 1999, 283 (5400) :357-362